Postoperative autologous blood salvage drains - Are they useful in primary uncemented hip and knee arthroplasty? A prospective study of 186 cases

Acta Orthopaedica Belgica

Volumn 70, Issue 5, 2004, Pages 466-473

  Jones, Henry Wynn ^a,c   Savage, Laura ^a   White, Craig ^a   Goddard, Richard ^a   Lumley, Hillary ^a   Kashif, Fadil ^a   Gurusany, Kurinchi ^a,b  

^a MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

^b PETERBOROUGH DISTRICT HOSPITAL   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGE; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; COST EFFECTIVENESS ANALYSIS; DRAIN; FEMALE; GENDER; HEALTH CARE COST; HEMOGLOBIN DETERMINATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PROSPECTIVE STUDY; SAFETY; SUCTION DRAINAGE; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TOURNIQUET; UNITED KINGDOM; WOUND DRAINAGE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; BONE CEMENTS; COHORT STUDIES; COST-BENEFIT ANALYSIS; DRAINAGE; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; TREATMENT OUTCOME;

EID: 8444232830     PISSN: 00016462     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Ayers DC, Murray DG, Duerr DM. Blood salvage after total hip arthroplasty. J Bone Joint Surg 1995; 77-A: 1347-1351.
2. Blevins FT, Shaw B, Valeri CR et al. Re-infusion of shed blood after orthopaedic procedures in children and adolescents. J Bone Joint Surg 1993; 75-A: 363-371.
3. Bengtson JP, Backman L, Stenqvist O et al. Complement activation and re-infusion of wound drainage blood. Anesthesiology 1990; 73: 376-80.
4. Billote DB, Glisson SN, Green D, Wixson RL. A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg 2002; 84-A: 299-304.
5. Borghi B, Casati A. Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli Study Group on Orthopaedic Anaesthesia 2000; 17: 411-417.
6. Clements DH. Salvage and re-infusion of postoperative sanguineous wound drainage. J Bone Joint Surg 1992; 74-A: 646-651.
7. Cohen ND, Munoz A, Reitz BA et al. Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med 1989; 320: 1172-1176.
8. Cushner FD, Friedman RJ. Blood loss in total knee arthroplasty. Clin Orthop 1991; 269: 98-101.
9. Dalen T, Nilsson KG, Engstrom GK. Fever and autologous blood retransfusion after knee arthroplasty; a prospective study of 40 autotransfusion events in 21 patients. Acta Orthop Scand 2002; 73: 321-325.
10. Dalén T, Skak S, Thorsen K, Fredin H. The efficacy and safety of blood re-infusion in avoiding homologous transfusion after total knee arthroplasty. Am J Knee Surg 1996; 9: 117-120.
11. de Andrade JR, Jove M, Landon G et al. Baseline hemoglobin as a predictor of risk of transfusion and response to epoetin alfa in orthopedic surgery patients. Am J Orthop 1996; 25: 533-542.
12. Etchason J, Petz L, Keeler E et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995, 332: 719-724.
13. Faris PM, Ritter MA, Abels RI. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J Bone Joint Surg 1996; 78-A: 62-72.
14. Faris PM, Ritter MA, Keating EM, Valeri CR. Unwashed filtered shed blood collected after knee and hip arthroplasties. J Bone Joint Surg 1991; 73-A: 69-78.
15. Fernandez MC. Gottlieb M. Menitove JE. Blood transfusion and postoperative infection in orthopedic patients. Transfusion 1992; 32: 318-322.
16. Forgie MA, Wells PS, Laupacis A, Fergusson D. Preoperative autologous donation decreases allogenic transfusion but increases exposure to all red blood cell transfusion: Results of a meta-analysis. Arch Int Med 1998; 158: 610-617.
17. Gannon DM, Lombardi AV Jr, Mallory TH et al. An evaluation of the efficacy of postoperative blood salvage after total joint arthroplasty. A prospective randomized trial. J Arthroplasty 1991; 6: 109-114.
18. Goldman M, Savard R, Long A et al. Declining value of preoperative autologous donation, Transfusion 2002; 42: 819-823.
19. Guerra J, Cuckler JM. Cost effectiveness of intra-operative autotransfusion in total hip arthroplasty surgery. Clin Orthop 1995; 315: 212-222.
20. Harley BJ, Beaupre LA, Jones CA et al. The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: a pilot study. Can J Surg 2002; 45: 185-190.
21. Hays MB, Mayfield JF. Total blood loss in major joint arthroplasty. A comparison of cemented and noncemented hip and knee operations. J Arthroplasty 1988, 3 (Suppl): 47-49.
22. Heim AT, Karski MT, Parsons SJ et al. A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery: Audit of an algorithm for arthroplasty of the lower limb. J Bone Joint Surg 2003; 85-B: 484-490.
23. Ho KM, Ismail H. Use of intravenous tranexamic acid to reduce allogenic blood transfusion in total hip and knee arthroplasty: A meta-analysis. Anaesth Intensive Care 2003; 31: 529-537.
24. Jensen CM, Pilegaard R, Hviid K et al. Quality of reinfused drainage blood after total knee arthroplasty. J Arthroplasty 1999; 14: 312-318.
25. Keating EM, Ritter MA. Transfusion options in total joint arthroplasty. J Arthroplasty 2002; 17 (Suppl 1): 125-128.
26. Krohn CD, Reikeras O, Bjornsen S, Brosstad F. Fibrinolytic activity and postoperative salvaged untreated blood for autologous transfusion in major orthopaedic surgery. Eur J Surg 2001; 167: 168-172.
27. Levy O, Martinowitz U, Oran A et al. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty: A prospective, randomized, multicenter study. J Bone Joint Surg 1999; 81-A: 1580-1588.
28. Marks RM, Vaccaro AR, Balderston RA et al. Postoperative blood salvage in total knee arthroplasty using the Solcotrans Autotransfusion System. JArthroplasty 1995, 10: 433-437.
29. Mezrow C, Bergstein I, Tartter PL. Postoperative infections following autologous and homologous blood transfusions. Transfusion 1992; 32: 27-30.
30. Murphy P, Heal JM, Blumberg N. Infections or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 1991; 31: 212-217.
31. Nelson KE, Donahue JG, Munoz A et al. Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections. Ann Int Med 1992; 117:554-559.
32. Ness PM, Bourke DL, Walsh PC. A randomized trial of perioperative hemodilution versus transfusion of preoperatively deposited autologous blood in elective surgery. Transfusion 1992, 32: 226-230.
33. Newman JH, Bowers M, Murphy J. The clinical advantages of autologous transfusion. A randomized, controlled study after knee replacement. J Bone Joint Surg 1997; 79-B: 630-632.
34. Nuttal GA, Santrach PJ, Oliver WC Jr et al. The predictors of red cell transfusions in total hip arthroplasties. Transfusion 1996; 36: 144-149.
35. Peter VK, Radford M, Matthews MG. Re-transfusion of autologous blood from wound drains: the means for reducing transfusion requirements in total knee arthroplasty. Knee 2001; 8: 321-323.
36. Pillonel J, Laperche S; Groupe "Agents Transmissibles par Transfusion" de la Société française de transfusion sanguine; Etablissements français du sang; Centre de transfusion sanguine des armées. Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing). Transfus Clin Biol 2004; 11: 81-86.
37. Pitsaer E. Transfusion of recuperated blood in total knee arthroplasty. Rev Chir Orthop 2002; 88: 777-789 (in French).
38. Rauh MA, Bayers-Thering M, LaButti RS, Krackow KA. Preoperative administration of epoetin alfa to total joint arthroplasty patients. Orthopedics 2002; 25: 317-321.
39. Regan F, Hewitt P, Barbara J et al. Prospective investigation of transfusion transmitted infection in recipients of over 20000 units of blood. Br Med J 2000; 320: 403-406.
40. Rosencher N, Kerkkamp HE, Macheras G et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43: 459-469.
41. Slagis SV, Benjamin JB, Volz RG, Giordano GF. Postoperative blood salvage in total hip and knee arthroplasty: a randomised controlled trial. J Bone Joint Surg 1991; 73-B: 591-594.
42. Southern EP, Huo MH, Mehta JR, Keggi KJ. Unwashed wound drainage blood. What are we giving our patients? Clin Orthop 1995; 320: 235-246.
43. Torella F, Haynes SL, Lardi A, O'Dwyer ST, McCollum CN. Unchanging attitudes to autologous transfusion in the UK. Transfusion Medicine 2001; 11: 15-19.
44. Umlas J, Foster RR, Dala SA et al. Red cell loss following orthopaedic surgery: the case against postoperative blood salvage. Transfusion 1994; 34: 402-406.
45. Umlas J, Jacobson MS, Kevy SV. Survival and half-life of red cells salvaged after hip and knee replacement surgery. Transfusion 1993; 33: 591-593.